RxDoctor Payments Data

Ching Wei Chen

Clinical Cardiac Electrophysiology · West Islip, NYNPI 1023350352

Payments from drug & device makers

$23,645in general payments, 2019–2025

Across 258 payments — averaging $91.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Medtronic$6K
  • Boston Scientific$4K
  • Kestra Medical Technology Services, Inc.$3K
  • Biosense Webster, Inc.$3K
  • Medical Device Business Services, Inc.$473
  • plus $1K from 17 others

What the payments were for

  • Speaking & faculty fees$2,25010%
  • Travel & lodging$8,17235%
  • Food & beverage$12,81454%
  • Education$4092%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,645 in reported general payments places this provider in the 40th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York

Medicare billing

Part B allowed, 2024
$364,502
Medicare patients
798
Services billed
4,228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban100$88,389
XareltoRivaroxaban18$21,502
Metoprolol Succinate105$2,074
Amiodarone Hcl56$1,240
Diltiazem 24hr Er (Cd)Diltiazem Hcl32$751
Flecainide Acetate27$526
ClopidogrelClopidogrel Bisulfate33$325
SotalolSotalol Hcl23$244
Atorvastatin Calcium24$198
Metoprolol Tartrate29$97
Furosemide20$76
Amlodipine Besylate20$63
Carvedilol11$59
Losartan Potassium14$39

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$167$88,389100 claims
Johnson & JohnsonXarelto$15$21,50218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 214 clinical cardiac electrophysiology providers in New York.

Other clinical cardiac electrophysiology in West Islip

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →